Policy Brief
Our Policy Brief presents research in a clear, concise, and engaging format, designed to support high-level executives and policy decision-makers in using evidence-based information to inform effective policy development and implementation.
Highlight Policy Brief
No information found
Policy Brief
56 issues
All (56)
Issue No. 26
Rare diseases – Talk of the Town for Some Time but What’s Next?
By :
Phornnaphat Chertchinnapa, Annapoorna Prakash
Issue No. 24
Experience in Using HTA for Expanding UHC Benefit Package to Cover Rare Diseases and High-Cost Drugs among Seven Middle and High-Income Countries: A targeted literature review
By :
Kumaree Pachanee, Dian Faradiba
Issue No. 149
Health Financing during COVID-19 responses in Thailand
By :
Papada Ranron, Praewa Kulatnam, Aungsumalee Pholpark, Sikarn lssarachaiyos
Issue No. 23
Learning from Cancer Drug Fund (CDF) in England: A special reimbursement pathway for high-cost cancer drugs
By :
Dian Faradiba
Issue No. 22
Horizon Scanning in the European Union
By :
Dian Faradiba, Dr. Dimple Butani, Mr. Nyi Nyi Zayar
Issue No. 21
The Life Saving Drug Program: Australia’s pathway to high-cost drugs
By :
Evan Huang-Ku, Dr. Tracey Laba
Issue No. 145
Unpacking Digital Health: A breakdown of concepts and definitions
By :
Dr. Dimple Butani
Issue No. 142
High-Cost Users Still Came to Hospitals During the COVID-19 Pandemic in Thailand
By :
Wanrudee Isaranuwatchai, PhD, Picharee Karunayawong, Dr. Piyada Gaewkhiew, Chulathip Boonma, Myka Harun Sarajan
Issue No. 121
Distributing ‘Smart Watch’ alone cannot reduce Sedentary Behavior. An Active Lifestyle can be encouraged by harmonizing Individual, Social, Organizational, and Environmental levels.
By :
Katika Akksilp, M.D.
